title: Hypereosinophilic syndrome in the tyrosine kinase inhibitor era.
authors: Department of Hematology, Nephrology, and Rheumatology, Akita University School of Medicine, Japan.
authors: Naoto
authors: N
authors: Takahashi
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001549:Benzamides / Q000008:administration & dosage*; D004802:Eosinophilia / Q000188:drug therapy*; D006801:Humans; D007951:Leukemia, Myeloid / Q000175:diagnosis* / Q000188:drug therapy*; D008297:Male; D015514:Oncogene Proteins, Fusion / Q000302:isolation & purification*; D010879:Piperazines / Q000008:administration & dosage*; D011743:Pyrimidines / Q000008:administration & dosage*; D020796:Receptor, Platelet-Derived Growth Factor alpha / Q000302:isolation & purification*; D039221:mRNA Cleavage and Polyadenylation Factors / Q000302:isolation & purification*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D015514:Oncogene Proteins, Fusion; D010879:Piperazines; D011743:Pyrimidines; D039221:mRNA Cleavage and Polyadenylation Factors; D020796:Receptor, Platelet-Derived Growth Factor alpha